keyword
https://read.qxmd.com/read/38748939/pertuzumab-plus-trastuzumab-in-patients-with-biliary-tract-cancer-with-erbb2-3-alterations-results-from-the-targeted-agent-and-profiling-utilization-registry-study
#1
JOURNAL ARTICLE
Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu, Jimmy Hwang, Namrata Vijayvergia, Olatunji B Alese, Elie G Dib, Herbert L Duvivier, Kelsey A Klute, Vaibhav Sahai, Eugene R Ahn, Pablo Bedano, Deepti Behl, Sarah Sinclair, Ramya Thota, Walter J Urba, Eddy S Yang, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
PURPOSE: Targeted Agent and Profiling Utilization Registry is a phase II basket trial evaluating the antitumor activity of commercially available targeted agents in patients with advanced cancer and genomic alterations known to be drug targets. Results of a cohort of patients with biliary tract cancer (BTC) with ERBB2/3 amplification, overexpression, or mutation treated with pertuzumab plus trastuzumab are reported. METHODS: Eligible patients had advanced BTC, measurable disease (RECIST v1...
May 15, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38745162/long-term-prognosis-after-endoscopic-submucosal-dissection-for-esophageal-cancer-in-older-adult-patients
#2
JOURNAL ARTICLE
Hirona Konishi, Yuji Urabe, Takeo Nakamura, Kazuki Ishibashi, Junichi Mizuno, Motomitsu Fukuhara, Takeshi Takasago, Hidenori Tanaka, Akiyoshi Tsuboi, Ken Yamashita, Yuichi Hiyama, Hidehiko Takigawa, Takahiro Kotachi, Ryo Yuge, Akira Ishikawa, Shiro Oka
BACKGROUND: The validity of endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) in older individuals with comorbidities remains unclear. Therefore, this study evaluated the safety and efficacy of ESD and additional treatment for ESCC in older adult patients. METHODS: The clinicopathological characteristics and clinical outcomes of 398 consecutive older adult patients (≥ 65 years) with 505 lesions who underwent ESD for ESCC at the Hiroshima University Hospital between September 2007 and December 2019 were retrospectively evaluated...
May 14, 2024: BMC Gastroenterology
https://read.qxmd.com/read/38741943/clinical-characteristics-prognosis-and-treatment-of-bloodstream-infections-with-enterobacter-cloacae-complex-in-a-chinese-tertiary-hospital-a-retrospective-study
#3
JOURNAL ARTICLE
Yanhua Liu, Fuxing Li, Youling Fang, Qiaoshi Zhong, Yanping Xiao, Yunwei Zheng, Junqi Zhu, Chuwen Zhao, Xingwei Cao, Jianqiu Xiong, Longhua Hu
OBJECTIVE: This research aimed to analyze the clinical characteristics, prognosis, and antimicrobial treatment of bloodstream infections (BSI) caused by Enterobacter cloacae complex (ECC). METHODS: The clinical data of patients with bloodstream infections caused by Enterobacter cloacae complex from April 2017 to June 2023 were collected retrospectively. These data were then analyzed in subgroups based on the detection results of extended-spectrum β-lactamase (ESBL), 30-day mortality, and the type of antimicrobial agent used (β-lactam/β-lactamase inhibitor combinations (BLICs) or carbapenems)...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38741429/fatal-pulmonary-bile-embolism-associated-with-acute-pancreatitis-a-case-report-and-review-of-the-literature
#4
REVIEW
Michał Knapik, Krzysztof Okoń, Magdalena Ulatowska-Białas
A 27-year-old woman with jaundice and abdominal pain was admitted to an emergency ward. The diagnostic process showed that gallstones were causing her symptoms. The patient was treated via endoscopic retrograde cholangiopancreatography (ERCP), and during the procedure she suffered a cardiac arrest. Autopsy findings included multiple pulmonary bile emboli as well as features of disseminated intravascular coagulation. Among 22 thus far described cases of bile pulmonary embolism, 13 were associated with medical procedures involving the liver and biliary tract...
2024: Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists
https://read.qxmd.com/read/38741060/a-new-model-of-portal-vein-thrombosis-in-rats-with-cirrhosis-induced-by-partial-portal-vein-ligation-plus-carbon-tetrachloride-and-intervened-with-rivaroxaban
#5
JOURNAL ARTICLE
Yanan Guo, Sisi Dong, Meng Li, Yanyan Tao, Jing Lv, Chenghai Liu
BACKGROUND AND AIMS: Portal vein thrombosis (PVT) is a common complication of liver cirrhosis that can aggravate portal hypertension. However, there are features of both PVT and cirrhosis that are not recapitulated in most current animal models. In this study, we aimed to establish a stable animal model of PVT and cirrhosis, intervene with anticoagulant, and explore the related mechanism. METHODS: First, 49 male SD rats received partial portal vein ligation (PPVL), and 44 survival rats were divided into 6 groups: PPVL control group; 4-week, 6 -week, 8-week, and 10-week model group; and the rivaroxaban (RIVA)-treated group...
May 13, 2024: BMC Gastroenterology
https://read.qxmd.com/read/38735814/improved-outcomes-of-liver-resection-for-hepatitis-c-related-hepatocellular-carcinoma-after-the-introduction-of-direct-acting-antiviral-therapy
#6
JOURNAL ARTICLE
Chiara Rocha, Joseph Di Norcia, Parissa Tabrizian, Chiara Di Renzo, Salvatore Amodeo, Yuki Bekki, Mohammed Z Akhtar, Marcelo E Facciuto, Thomas D Schiano, Sander Florman, Myron Schwartz
BACKGROUND: Assess impact of direct-acting antivirals introduction on outcomes after liver resection for hepatocellular carcinoma. METHODS: 391 patients (1991-2021) treated with resection for hepatocellular carcinoma on Hepatitis C background were divided according to receiving Hepatitis C treatment, treatment type, achievement of sustained virological response (SVR), time of resection pre- (Era 1, 1991-2011) and post-direct acting antivirals introduction (Era 2, 2012-2021)...
April 30, 2024: HPB: the Official Journal of the International Hepato Pancreato Biliary Association
https://read.qxmd.com/read/38735795/off-label-use-of-lumen-apposing-metal-stents-for-treatment-of-short-benign-biliary-strictures
#7
JOURNAL ARTICLE
Massimiliano Mutignani, Mario Capasso, Giulia Bonato, Francesco Pugliese, Lorenzo Dioscoridi, Marcello Cintolo, Marianna Bravo, Andrea Palermo, Irene Cottone, Edoardo Forti
BACKGROUND: Endoscopic stenting is the mainstay of treatment for benign biliary strictures. There is a not-negligible rate of recurrence and stent migration. Lumen-apposing metal stents (LAMS) have a unique design with short length, large diameter and wide flanges which make them less prone to migration. AIMS: To describe the intraluminal use of LAMS to treat short benign biliary strictures. METHODS: All consecutive patients who underwent bi-flanged LAMS placement for benign biliary strictures, in approximately 6 years, were retrospectively included...
May 11, 2024: Digestive and Liver Disease
https://read.qxmd.com/read/38735698/vagus-nerve-stimulation-in-bursts-can-efficiently-modulate-gastric-contractions-and-contraction-frequency-at-varying-gastric-pressures
#8
JOURNAL ARTICLE
D Tovbis, P B Yoo
OBJECTIVE: There has been recent clinical interest in the use of vagus nerve stimulation (VNS) for treating gastrointestinal disorders as an alternative to drugs or gastric electrical stimulation. However, effectiveness of burst stimulation has not been demonstrated. We investigated the ability of bursting and continuous VNS to influence gastric and pyloric activity under a range of stimulation parameters and gastric pressures. The goals of this study were to determine which parameters could optimally excite or inhibit gastric activity...
May 12, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38734151/effects-of-pethoxamid-treatment-on-the-disposition-of-thyroxine-in-rats
#9
JOURNAL ARTICLE
Appavu Chandrasekaran, Karin Bentley, Robert McClanahan, Gopinath Nallani
Pethoxamid (PXA) is a chloroacetamide herbicide that works by inhibiting the germination of target weeds in crops. PXA is not a genotoxic agent, however, in a two-year chronic toxicity study, incidence of thyroid follicular cell hyperplasia was observed in male rats treated at a high dose. Many non-mutagenic chemicals, including agrochemicals are known to produce thyroid hyperplasia in rodents through a hepatic metabolizing enzyme induction mode of action (MoA). In this study, the effects of oral gavage PXA treatment at 300 mg/kg for 7 days on the disposition of intravenously (iv) administered radio-labeled thyroxine ([125 I]-T4) was assessed in bile-duct cannulated (BDC) rats...
May 9, 2024: Toxicology and Applied Pharmacology
https://read.qxmd.com/read/38733616/dominant-stricture-in-paediatric-onset-primary-sclerosing-cholangitis-is-associated-with-impaired-prognosis-in-a-long-term-follow-up
#10
JOURNAL ARTICLE
Andrea Tenca, Kaija-Leena Kolho, Dario Consonni, Kalle Jokelainen, Martti Färkkilä
BACKGROUND AND OBJECTIVES: The impact of dominant stricture (DS) on the outcomes of paediatric-onset primary sclerosing cholangitis (PSC) is unknown. This study was aimed at investigating the impact of DS on the clinical course and prognosis of patients with paediatric-onset PSC. METHODS: Patients with paediatric-onset PSC diagnosed between January 1993 and May 2017 were identified from hospital records or our PSC registry. Data including clinical, laboratory, cholangiography, and cytology at diagnosis and during follow-up (until July 2023) were reviewed...
May 11, 2024: United European Gastroenterology Journal
https://read.qxmd.com/read/38733420/the-response-of-pancreatic-acinar-cell-carcinoma-to-platinum-and-olaparib-therapy-in-a-germline-brca2-variant-carrier-case-report-and-literature-review
#11
JOURNAL ARTICLE
Hiroyuki Matsubayashi, Akiko Todaka, Takahiro Tsushima, Yoshimi Kiyozumi, Rina Harada, Eiko Ishihara, Satomi Higashigawa, Nobuyuki Ohike, Hiroki Sakamoto, Junya Sato, Hirotoshi Ishiwatari, Teichi Sugiura, Katsuhiko Uesaka
A 73-year-old Japanese man with a history of distal biliary cancer treated by pancreatoduodenectomy developed pancreatic acinar cell carcinoma (PACC) treated by remnant pancreatectomy and adjuvant chemotherapy. Thirteen months after surgery, multiple liver metastases developed and FOLFOX chemotherapy was initiated. Based on the PACC diagnosis and a positive family history for breast and ovarian cancer genetic testing was performed which revealed a pathogenic germline BRCA2 variant (c.8629G > T, p...
May 11, 2024: Familial Cancer
https://read.qxmd.com/read/38731973/wilson-disease-copper-mediated-cuproptosis-iron-related-ferroptosis-and-clinical-highlights-with-comprehensive-and-critical-analysis-update
#12
REVIEW
Rolf Teschke, Axel Eickhoff
Wilson disease is a genetic disorder of the liver characterized by excess accumulation of copper, which is found ubiquitously on earth and normally enters the human body in small amounts via the food chain. Many interesting disease details were published on the mechanistic steps, such as the generation of reactive oxygen species (ROS) and cuproptosis causing a copper dependent cell death. In the liver of patients with Wilson disease, also, increased iron deposits were found that may lead to iron-related ferroptosis responsible for phospholipid peroxidation within membranes of subcellular organelles...
April 26, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38731224/the-diagnosis-and-treatment-of-acute-cholecystitis-a-comprehensive-narrative-review-for-a-practical-approach
#13
REVIEW
Lara Mencarini, Amanda Vestito, Rocco Maurizio Zagari, Marco Montagnani
Acute cholecystitis (AC), generally associated with the presence of gallstones, is a relatively frequent disease that can lead to serious complications. For these reasons, AC warrants prompt clinical diagnosis and management. There is general agreement in terms of considering early laparoscopic cholecystectomy (ELC) to be the best treatment for AC. The optimal timeframe to perform ELC is within 72 h from diagnosis, with a possible extension of up to 7-10 days from symptom onset. In the first hours or days after hospital admission, before an ELC procedure, the patient's medical management comprises fasting, intravenous fluid infusion, antimicrobial therapy, and possible administration of analgesics...
May 3, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38730690/the-impact-of-the-covid-19-pandemic-on-time-to-treatment-in-surgical-oncology-a-national-registry-study-in-the-netherlands
#14
JOURNAL ARTICLE
Roos M G van Vuren, Yester F Janssen, Rianne N M Hogenbirk, Michelle R de Graaff, Rinske van den Hoek, Schelto Kruijff, David J Heineman, Willemijn Y van der Plas, Michel W J M Wouters
UNLABELLED: To avoid delay in oncological treatment, a 6-weeks norm for time to treatment has been agreed on in The Netherlands. However, the impact of the COVID-19 pandemic on health systems resulted in reduced capacity for regular surgical care. In this study, we investigated the impact of the COVID-19 pandemic on time to treatment in surgical oncology in The Netherlands. METHODS: A population-based analysis of data derived from five surgical audits, including patients who underwent surgery for lung cancer, colorectal cancer, upper gastro-intestinal, and hepato-pancreato-biliary (HPB) malignancies, was performed...
April 29, 2024: Cancers
https://read.qxmd.com/read/38725401/outcomes-of-partially-covered-self-expandable-metal-stents-with-different-uncovered-lengths-in-endoscopic-ultrasound-guided-hepaticogastrostomy-a-japanese-retrospective-study
#15
JOURNAL ARTICLE
Takeshi Okamoto, Takashi Sasaki, Tsuyoshi Takeda, Tatsuki Hirai, Takahiro Ishitsuka, Manabu Yamada, Hiroki Nakagawa, Takafumi Mie, Takaaki Furukawa, Akiyoshi Kasuga, Masato Ozaka, Naoki Sasahira
BACKGROUND/AIMS: The optimal length of the uncovered portion of partially covered self-expandable metal stents (PCSEMSs) used in endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) remains unclear. This study investigated the safety and efficacy of PCSEMSs with different uncovered lengths, with a focus on stent migration and time to recurrent biliary obstruction (RBO). METHODS: Outcomes of patients undergoing EUS-HGS using PCSEMSs with 5-mm and 20-mm uncovered portions at our institution from January 2016 to December 2021 were compared...
May 10, 2024: Clinical Endoscopy
https://read.qxmd.com/read/38723644/maralixibat-in-progressive-familial-intrahepatic-cholestasis-march-pfic-a-multicentre-randomised-double-blind-placebo-controlled-phase-3-trial
#16
JOURNAL ARTICLE
Alexander G Miethke, Adib Moukarzel, Gilda Porta, Joshue Covarrubias Esquer, Piotr Czubkowski, Felipe Ordonez, Antonella Mosca, Amal A Aqul, Robert H Squires, Etienne Sokal, Daniel D'Agostino, Ulrich Baumann, Lorenzo D'Antiga, Nagraj Kasi, Nolwenn Laborde, Cigdem Arikan, Chuan-Hao Lin, Susan Gilmour, Naveen Mittal, Fang Kuan Chiou, Simon P Horslen, Wolf-Dietrich Huber, Thomas Jaecklin, Tiago Nunes, Anamaria Lascau, Lara Longpre, Douglas B Mogul, Will Garner, Pamela Vig, Vera F Hupertz, Regino P Gonzalez-Peralta, Udeme Ekong, Jane Hartley, Noemie Laverdure, Nadia Ovchinsky, Richard J Thompson
BACKGROUND: Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive disorders, the most prevalent being BSEP deficiency, resulting in disrupted bile formation, cholestasis, and pruritus. Building on a previous phase 2 study, we aimed to evaluate the efficacy and safety of maralixibat-an ileal bile acid transporter inhibitor-in participants with all types of PFIC. METHODS: MARCH-PFIC was a multicentre, randomised, double-blind, placebo-controlled, phase 3 study conducted in 29 community and hospital centres across 16 countries in Europe, the Americas, and Asia...
May 6, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38722378/prognosis-of-patients-with-advanced-bile-tract-carcinoma-assessment-using-the-modified-gustave-roussy-immune-score-mgrim-s-as-a-clinico-immunological-tool
#17
JOURNAL ARTICLE
Yue Ma, Yuting Pan, Yue Li, Huafang Guan, Guanghai Dai
BACKGROUND: The emergence of immune checkpoint inhibitors (ICIs) has enhanced survival outcomes for certain patients with advanced biliary tract carcinoma (BTC). Pinpointing those who would benefit most from immunotherapy remains elusive. We investigated the predictive value of the modified Gustave Roussy Immune Score (mGRIm-s) in BTC patients treated with ICIs. METHODS: Data from 110 patients at Chinese People's Liberation Army General Hospital, spanning September 2015 to April 2021, were analyzed...
May 9, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38720868/a-novel-technique-of-percutaneous-transhepatic-treatment-of-biliary-enteric-anastomotic-occlusive-strictures-with-compliant-balloon-occluded-distal-cholangiography-and-large-bore-catheter-a-retrospective-case-series
#18
JOURNAL ARTICLE
Chaojie Li, Ju Gong, Wei Huang, Qungang Shan, Ziyin Wang, Zhongmin Wang
BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic biliary balloon dilatation (PTBD) is a challenge in resolving biliary-enteric anastomotic occlusive strictures (BEAOS) and/or coexisting stones. The biliary-enteric anastomosis (BEA) often cannot be seen because of the surgically altered gastrointestinal anatomy. Here, a technique that combined percutaneous compliant-occluded distal cholangiography and the maintenance of a large-bore catheter is described to resolve this issue...
May 1, 2024: Quantitative Imaging in Medicine and Surgery
https://read.qxmd.com/read/38708468/liver-cirrhosis-in-a-patient-with-alcohol-dependence-and-autoimmune-hepatitis
#19
JOURNAL ARTICLE
R Cioarca-Nedelcu, V Atanasiu, B E Istratie, D Nistor, M Proks, E Maghet, M Preda, I Stoian
BACKGROUND: Liver cirrhosis is the end-stage entity for a wide variety of chronic liver pathologies. These include viral hepatitis B and C, alcoholic liver disease, non-alcoholic fatty liver disease, hemochromatosis, Wilson disease, autoimmune hepatitis, primary sclerosing cholangitis, and primary biliary cirrhosis. In the majority of cases, liver cirrhosis remains completely asymptomatic until acute decompensation occurs. Patients may present complications of portal hypertension such as gastro-esophageal varices and upper digestive hemorrhage, ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, or hepato-renal syndrome...
April 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38706473/enhancing-biliary-structure-identification-using-percutaneous-cholecystostomy-drain-delivery-of-indocyanine-green-a-glowing-two-case-review
#20
Peter Alexander, Vincent Marcucci, Patricia Torres, Jillian Cassidy, Seth Kipnis, Dena Arumugam
The use of indocyanine green for fluorescent cholangiography in patients with cholecystitis initially treated with percutaneous cholecystostomy drainage catheters was described in this two case series. Two patients underwent robotic assisted cholecystectomy with fluorescent cholangiography and indocyanine green through percutaneous cholecystostomy drainage catheters. The patients were diagnosed with acute cholecystitis. Directed injection of indocyanine green allowed for direct visualization of the biliary system allowing for a safe identification of the critical view of safety...
May 2024: Journal of Surgical Case Reports
keyword
keyword
55998
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.